Skip to main content

MoneyWorks4Me

Medicamen Biotech informs about details of loss of certificate

05 Aug 2022 Evaluate
In terms of Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Medicamen Biotech has informed that the Company has received request for issuance of duplicate share certificates in lieu of share certificates reported lost.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1776.00
Dr. Reddys Labs. 1372.00
Cipla 1400.10
Lupin 2015.00
Zydus Lifesciences 1190.00
View more..